Changmao Biochemical Engineering Company Limited provided consolidated earnings guidance for the year ended December 31, 2018. The board of directors of the company announced that having assessed the currently available information, the Group is likely to record a consolidated net profit attributable to the equity holders of the company for the year ended December 31, 2018 of approximately RMB 45,000,000 to RMB 55,000,000, which represent a significant increase as compared to that of approximately RMB 3,382,000 for the year ended 31 December 2017.